STERIS plc $STE Stake Lifted by Ieq Capital LLC

Ieq Capital LLC boosted its position in shares of STERIS plc (NYSE:STE – Free Report) by 41.3% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 45,698 shares of the medical equipment provider’s stock after buying an additional 13,352 shares during the quarter. Ieq Capital LLC’s holdings in STERIS were worth $9,597,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in STE. NewEdge Advisors LLC raised its position in STERIS by 0.7% during the second quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock valued at $1,710,000 after acquiring an additional 56 shares in the last quarter. Taylor Frigon Capital Management LLC lifted its position in STERIS by 0.9% during the 3rd quarter. Taylor Frigon Capital Management LLC now owns 6,505 shares of the medical equipment provider’s stock worth $1,366,000 after buying an additional 58 shares in the last quarter. Strengthening Families & Communities LLC raised its holdings in STERIS by 0.6% during the 3rd quarter. Strengthening Families & Communities LLC now owns 10,884 shares of the medical equipment provider’s stock worth $2,286,000 after purchasing an additional 61 shares during the last quarter. Mather Group LLC. raised its position in shares of STERIS by 14.4% in the 3rd quarter. Mather Group LLC. now owns 565 shares of the medical equipment provider’s stock valued at $119,000 after acquiring an additional 71 shares during the period. Finally, Community Financial Services Group LLC lifted its holdings in shares of STERIS by 50.0% during the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 72 shares in the last quarter. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Trading Up 0.4%

NYSE STE opened at $255.66 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.05 and a quick ratio of 1.44. The stock has a market capitalization of $24.83 billion, a price-to-earnings ratio of 30.33 and a beta of 0.86. STERIS plc has a one year low of $195.14 and a one year high of $269.44. The business’s fifty day moving average is $227.43 and its 200-day moving average is $224.49.

STERIS (NYSE:STE – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.26. The company had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.56 billion. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.47 EPS. Equities research analysts predict that STERIS plc will post 11.46 EPS for the current year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Tuesday, November 17th will be paid a $0.69 dividend. The ex-dividend date is Tuesday, November 17th. This represents a $2.76 annualized dividend and a yield of 1.1%. STERIS’s dividend payout ratio (DPR) is currently 32.74%.

Analyst Ratings Changes

Several research firms recently issued reports on STE. Jefferies Financial Group upgraded STERIS from a “hold” rating to a “buy” rating and upped their target price for the stock from $232.00 to $305.00 in a report on Friday, November 13th. Weiss Ratings upgraded STERIS from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, November 9th. Piper Sandler reiterated an “overweight” rating and set a $275.00 price objective (up from $270.00) on shares of STERIS in a research report on Friday, August 7th. UBS Group reduced their price target on STERIS from $275.00 to $270.00 and set a “buy” rating on the stock in a research report on Friday, August 7th. Finally, KeyCorp increased their price target on STERIS from $269.00 to $284.00 and gave the stock an “overweight” rating in a report on Friday, November 6th. Five investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $283.50.

View Our Latest Stock Analysis on STE

Insider Activity

In other STERIS news, VP Julia Madsen sold 2,046 shares of the stock in a transaction that occurred on Friday, November 13th. The shares were sold at an average price of $260.00, for a total value of $531,960.00. Following the sale, the vice president directly owned 10,211 shares in the company, valued at $2,654,860. This represents a 16.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Mohsen Sohi sold 4,893 shares of the business’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $253.22, for a total value of $1,239,005.46. Following the transaction, the director owned 24,305 shares of the company’s stock, valued at approximately $6,154,512.10. The trade was a 16.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 12,819 shares of company stock worth $3,274,011. 1.12% of the stock is owned by company insiders.

About STERIS

(Free Report)

STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.

Recommended Stories

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.